» Articles » PMID: 35955107

A Qualitative Exploration of the Functional, Social, and Emotional Impacts of the COVID-19 Pandemic on People Who Use Drugs

Overview
Publisher MDPI
Date 2022 Aug 12
PMID 35955107
Authors
Affiliations
Soon will be listed here.
Abstract

Since 2020, people who use drugs (PWUD) experienced heightened risks related to drug supply disruptions, contamination, overdose, social isolation, and increased stress. This study explored how the lives of PWUD changed in Philadelphia over a one-year period. Using semi-structured interviews with 20 participants in a Housing First, low-barrier medication for opioid use (MOUD) program in Philadelphia, the effects of the first year of the COVID-19 pandemic on the daily lives, resources, functioning, substance use, and treatment of PWUD were explored. Interviews were analyzed using a combination of directed and conventional content analysis. Six overarching themes emerged during data analysis: (1) response to the pandemic; (2) access to MOUD and support services; (3) substance use; (4) impacts on mental health, physical health, and daily functioning; (5) social network impacts; and (6) fulfillment of basic needs. Participants reported disruptions in every domain of life, challenges meeting their basic needs, and elevated risk for adverse events. MOUD service providers offset some risks and provided material supports, treatment, social interaction, and emotional support. These results highlight how there were significant disruptions to the lives of PWUD during the first year of the COVID-19 pandemic and identified critical areas for future intervention and policies.

Citing Articles

A cohort-based assessment of drug use trends during the COVID-19 pandemic: relationship with mood and sociodemographic factors in Brazil.

Heidrich N, Nin M, Almeida F, Constant H, Freese L, Barros H Front Psychiatry. 2025; 16:1514365.

PMID: 39980973 PMC: 11841454. DOI: 10.3389/fpsyt.2025.1514365.


Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland.

Patel E, Grieb S, Winiker A, Ching J, Schluth C, Mehta S Harm Reduct J. 2024; 21(1):91.

PMID: 38720307 PMC: 11077846. DOI: 10.1186/s12954-024-01008-8.


BeHERE's effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings.

Kenefick H, Wing A Harm Reduct J. 2024; 21(1):38.

PMID: 38351012 PMC: 10863279. DOI: 10.1186/s12954-024-00948-5.


Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns.

Sekeris A, Algahtani T, Aldabergenov D, Rock K, Auwal F, Aldewaissan F Front Public Health. 2023; 11:1232593.

PMID: 37841731 PMC: 10570433. DOI: 10.3389/fpubh.2023.1232593.


Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study.

Ali F, Kaura A, Russell C, Bonn M, Bruneau J, Dasgupta N Harm Reduct J. 2023; 20(1):99.

PMID: 37516836 PMC: 10387201. DOI: 10.1186/s12954-023-00826-6.


References
1.
Weinstein L, Iqbal Q, Cunningham A, DeBates R, Landistratis G, Doggett P . Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018. Am J Public Health. 2020; 110(4):580-586. PMC: 7067078. DOI: 10.2105/AJPH.2019.305525. View

2.
May T, Dawes J, Fancourt D, Burton A . A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives. Int J Drug Policy. 2022; 106:103752. PMC: 9135844. DOI: 10.1016/j.drugpo.2022.103752. View

3.
Cowan E, Khan M, Shastry S, Edelman E . Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model. Addict Sci Clin Pract. 2021; 16(1):4. PMC: 7789072. DOI: 10.1186/s13722-020-00210-w. View

4.
Hsieh H, Shannon S . Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9):1277-88. DOI: 10.1177/1049732305276687. View

5.
Collins A, Edwards S, McNeil R, Goldman J, Hallowell B, Scagos R . A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island. Int J Drug Policy. 2022; 103:103626. PMC: 8849851. DOI: 10.1016/j.drugpo.2022.103626. View